通过准金属ββ-乳糖酶VIM-1克服Pseudomonas aeruginosa中的β-乳糖酶抵抗:一微秒的分子动力学模拟研究
Mohammed Salleh M Ardawi1, Samar A Badreddine2, Muhammad Yasir3,4
1Department of Pathological Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
Frontiers in cellular and infection microbiology
|February 19, 2025
概括
针对金属β-乳糖酶VIM-1 (MBL-VIM-1) 的新抑制剂被确定用于对抗Pseudomonas aeruginosa的抗生素耐药性. 这些化合物表现出强烈的结合性和稳定性,可能恢复β-乳酸抗生素的疗效.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 计算化学的计算化学
背景情况:
- Pseudomonas aeruginosa 是一种格拉姆阴性病原体,因其对β-乳糖抗生素的高耐药性而闻名.
- 这种耐药性主要是由于金属β-乳糖酶VIM-1 (MBL-VIM-1) 酶的产生.
- 恢复β-乳糖的疗效对于治疗P. aeruginosa感染至关重要.
研究的目的:
- 为了确定针对MBL-VIM-1酶的新型抑制剂.
- 寻找可以恢复β-乳糖抗生素对抗耐药P. aeruginosa.有效性的化合物.
- 探索天然化合物作为潜在的治疗剂.
主要方法:
- 从COCONUT数据库中对自然化合物的虚拟选.
- 确定现有的MBL-VIM-1抑制剂的结构类型.
- 对接,重新对接,以及一微秒分子动力学 (MD) 模拟.
- 在MD后进行模拟计算,以评估结合亲和力和稳定性.
主要成果:
- 四个化合物 (CNP0390322,CNP03905695,CNP0079056,CNP0338283) 根据对接得分进行了选择.
- MD模拟证实了这些化合物的结合稳定性和相互作用在MBL-VIM-1活性部位.
- 与参考抑制剂相比,已识别的抑制剂显示出更高的结合亲和力和稳定性.
结论:
- 已识别的化合物是MBL-VIM-1的强有力的抑制剂.
- 这些抑制剂显示出对抗P. aeruginosa.抗生素耐药性的潜力.
- 需要进一步的体外和体内研究来验证这些发现的治疗发展.
相关概念视频
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


